This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Unlocking Q3 Potential of Marvell (MRVL): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Marvell (MRVL) for the quarter ended October 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Marvell Technology (MRVL) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
Marvell Technology (MRVL) closed the most recent trading day at $93.14, moving +0.98% from the previous trading session.
The Zacks Analyst Blog Highlights Super Micro Computer, Marvell and NVIDIA
by Zacks Equity Research
Super Micro Computer, Marvell and NVIDIA are included in this Analyst Blog.
Marvell Technology (MRVL) Stock Moves 0.58%: What You Should Know
by Zacks Equity Research
In the most recent trading session, Marvell Technology (MRVL) closed at $89.86, indicating a +0.58% shift from the previous trading day.
This Is Why SMCI Stock Bounced Back, and Why It's Time to Buy
by Tirthankar Chakraborty
With Supermicro appointing a new auditor and maintaining a strong position in the AI server market, capitalizing on the buying opportunities seems judicious.
Duos Technologies Group, Inc. (DUOT) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Duos Technologies Group, Inc. (DUOT) delivered earnings and revenue surprises of 4% and 15.68%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Should NVIDIA Stock be Part of Your Portfolio Ahead of Q3 Earnings?
by Anirudha Bhagat
NVDA's Q3 results are likely to reflect the benefits of strong demand for generative AI and LLM-supportive GPUs from data center operators.
Marvell Technology (MRVL) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
In the most recent trading session, Marvell Technology (MRVL) closed at $90.70, indicating a +0.7% shift from the previous trading day.
Marvell Soars 30% in Three Months: Should You Hold or Fold the Stock?
by Anirudha Bhagat
MRVL's 30% surge reflects its AI strength and data center growth, but export risks and valuation suggest holding the stock for now.
Marvell Technology, Inc. (MRVL) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Marvell (MRVL). This makes it worthwhile to examine what the stock has in store.
Bitfarms Ltd. (BITF) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Bitfarms (BITF) delivered earnings and revenue surprises of 25% and 0.38%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Is It Worth Investing in Marvell (MRVL) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Marvell (MRVL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
VerifyMe, Inc. (VRME) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
VerifyMe (VRME) delivered earnings and revenue surprises of 33.33% and 0.46%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Marvell Technology (MRVL) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
In the latest trading session, Marvell Technology (MRVL) closed at $93.80, marking a -0.15% move from the previous day.
ADTRAN Holdings (ADTN) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
ADTRAN Holdings (ADTN) delivered earnings and revenue surprises of -150% and 0.48%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Lesaka Technologies (LSAK) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lesaka Technologies (LSAK) delivered earnings and revenue surprises of -16.67% and 0.96%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Marvell Technology (MRVL) Registers a Bigger Fall Than the Market: Important Facts to Note
by Zacks Equity Research
Marvell Technology (MRVL) closed at $84.38 in the latest trading session, marking a -0.46% move from the prior day.
Marvell Technology, Inc. (MRVL) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Marvell (MRVL). This makes it worthwhile to examine what the stock has in store.
Marvell Technology (MRVL) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
The latest trading day saw Marvell Technology (MRVL) settling at $84.87, representing a +1.71% change from its previous close.
Marvell Technology (MRVL) Rises But Trails Market: What Investors Should Know
by Zacks Equity Research
In the most recent trading session, Marvell Technology (MRVL) closed at $81.93, indicating a +0.12% shift from the previous trading day.
Top Analyst Reports for SAP, Goldman Sachs & Lockheed Martin
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including SAP SE (SAP), The Goldman Sachs Group, Inc. (GS) and Lockheed Martin Corp. (LMT), as well as two micro-cap stocks AMREP Corp. (AXR) and Nova LifeStyle, Inc. (NVFY).
Marvell Technology (MRVL) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
Marvell Technology (MRVL) closed at $79.85 in the latest trading session, marking a -0.08% move from the prior day.
Investors Heavily Search Marvell Technology, Inc. (MRVL): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Marvell (MRVL) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Is Marvell (MRVL) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Marvell (MRVL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Marvell Soars 22% YTD: Should Investors Buy, Sell or Hold the Stock?
by Zacks Equity Research
While MRVL's exposure to China and elevated valuation are legitimate concerns, its promising product pipeline and efficient execution make the stock worth holding on to.